Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | CA1 | P00915 | 9/20 | 0.46 |
| ▸ | CA2 | P00918 | 9/20 | 0.46 |
| ▸ | CA9 | Q16790 | 8/20 | 0.46 |
| ▸ | CA12 | O43570 | 3/20 | 0.46 |
| ▸ | CA7 | P43166 | 3/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.46 |
| ▸ | CA3 | P07451 | 2/20 | 0.46 |
| ▸ | CA4 | P22748 | 2/20 | 0.46 |
| ▸ | CA6 | P23280 | 2/20 | 0.46 |
| ▸ | CA5A | P35218 | 2/20 | 0.46 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.46 |
| ▸ | RECQL | P46063 | 2/20 | 0.44 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4103317 | 1.00 | USP2 (0.59) | USP2KDM4EDUSP3MEN1KMT2A | |
| SCHEMBL8824126 | 0.98 | USP2 (0.57) | USP2KDM4EDUSP3MEN1KMT2A | |
| SCHEMBL4083788 | 0.98 | USP2 (0.57) | USP2KDM4EDUSP3MEN1KMT2A | |
| SCHEMBL8824125 | 0.98 | USP2 (0.57) | USP2KDM4EDUSP3MEN1KMT2A | |
| SCHEMBL9408828 | 0.98 | USP2 (0.57) | USP2KDM4EDUSP3MEN1KMT2A | |
| Ammonia Solution, Strong SCHEMBL8824144 | 0.98 | USP2 (0.57) | USP2KDM4EDUSP3MEN1KMT2A | |
| SCHEMBL21058284 | 0.98 | USP2 (0.57) | USP2KDM4EDUSP3MEN1KMT2A | |
| Ammonia Solution, Strong SCHEMBL8824133 | 0.98 | USP2 (0.57) | USP2KDM4EDUSP3MEN1KMT2A | |
| SCHEMBL4657281 | 0.98 | USP2 (0.56) | USP2KDM4EDUSP3MEN1KMT2A | |
| Methylamine SCHEMBL28157688 | 0.97 | USP2 (0.56) | USP2KDM4EDUSP3MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107446282-A | High-strength mechanical arm and preparation method thereof | 乔斌 | 2017-12-08 | — | — | CN | claimed |
| CN-107353624-A | A kind of high tenacity health-care wheel chair brake lever sheath and preparation method thereof | 安徽智联管理咨询有限公司 | 2017-11-17 | — | — | CN | claimed |
| CN-107298817-A | A kind of scratch-resistant mechanical arm | 乔斌 | 2017-10-27 | — | — | CN | claimed |
| US-20250268832-A1 | Pretomanid Compositions | THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC. | 2025-08-28 | — | — | US | disclosed |
| US-20230172943-A1 | ORAL SOLID MELOXICAM FORMULATIONS FOR THE TREATMENT OF ACUTE PAIN | MYLAN SPECIALTY L.P. (US) | 2023-06-08 | — | — | US | disclosed |
| EP-4164645-A1 | COMBINATION ANTIBACTERIAL COMPOSITION AND METHOD FOR ANTIBACTERIAL THERAPY | The Global Alliance for TB Drug Development, Inc. (US) | 2023-04-19 | — | — | EP | disclosed |
| EP-4164626-A1 | COMBINATION ANTIBACTERIAL COMPOSITION AND METHOD FOR ANTIBACTERIAL THERAPY | Mylan Laboratories Ltd. (IN) | 2023-04-19 | — | — | EP | disclosed |
| US-20220184095-A1 | MELOXICAM CO-CRYSTAL COMPOSITIONS | MYLAN SPECIALTY L P (US) | 2022-06-16 | — | — | US | disclosed |
| EP-3999039-A1 | PRETOMANID COMPOSITIONS | The Global Alliance for TB Drug Development, Inc. (US) | 2022-05-25 | — | — | EP | disclosed |
| EP-3958841-A1 | MELOXICAM CO-CRYSTAL COMPOSITIONS | Mylan Specialty L.P. (US) | 2022-03-02 | — | — | EP | disclosed |
| WO-2021257466-A1 | COMBINATION ANTIBACTERIAL COMPOSITION AND METHOD FOR ANTIBACTERIAL THERAPY | THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC. (US) | 2021-12-23 | — | — | WO | disclosed |
| CN-104558776-A | Antibacterial master batch and preparation method of antibacterial master batch, antibacterial artificial grass and preparation method of antibacterial artificial grass | GUANGZHOU ALL VICTORY GRASS CO LTD | 2015-04-29 | — | — | CN | disclosed |
| US-6136046-A | Interior base material and printing process thereof | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2000-10-24 | — | — | US | disclosed |
| US-5958547-A | Interior base material | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 1999-09-28 | — | — | US | disclosed |
| EP-0804147-B1 | DERMATO-COSMETOLOGIC COMPOSITION | FABRE PIERRE DERMO COSMETIQUE (FR) | 1998-10-07 | — | — | EP | disclosed |
| EP-0804147-A1 | DERMATO-COSMETOLOGIC COMPOSITION | PIERRE FABRE DERMO-COSMETIQUE (FR) | 1997-11-05 | — | — | EP | disclosed |
| EP-0412546-B1 | Light-sensitive microcapsule containing polymerizable compound and pigment particles | FUJI PHOTO FILM CO LTD (JP) | 1996-04-24 | — | — | EP | disclosed |
| WO-1995033443-A1 | DERMATO-COSMETOLOGIC COMPOSITION | PIERRE FABRE DERMO-COSMETIQUE (FR) | 1995-12-14 | — | — | WO | disclosed |
| US-5118590-A | Pigment particles surface treated with lipophilic resin or surfactant | FUJI PHOTO FILM CO., LTD. (JP) | 1992-06-02 | — | — | US | disclosed |
| US-4094806-A | SULFONATED ZINC PHTHALOCYANINE | THE PROCTER & GAMBLE COMPANY (US) | 1978-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220184095-A1 | MELOXICAM CO-CRYSTAL COMPOSITIONS | MB, MAX, MYADM | USP2 3235/4885KDM4E 3126/4885DUSP3 3230/4885 |
| US-20250268832-A1 | Pretomanid Compositions | HPSE, ALG3, ACMSD | USP2 160/4885KDM4E 3133/4885DUSP3 3740/4885 |
| US-20230172943-A1 | ORAL SOLID MELOXICAM FORMULATIONS FOR THE TREATMENT OF ACUTE PAIN | MB, MYADM, MLX | USP2 3198/4885KDM4E 3703/4885DUSP3 2294/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.